Free shipping and returns

 

2023-03-17 Money Today
Original News

EX Healthcare (CEO Lee Yong-hee) announced on the 17th that it has recently signed MOUs (Memorandums of Understanding) with U.S. companies and universities, marking a significant step in its efforts to enter the American market. The company has also secured investment from In and Out Corporation, further accelerating its expansion plans in the U.S.

EX Healthcare specializes in researching exosomes secreted from the skin and has developed the world's first topical healthcare solution. Recently, the company signed an MOU with Dalton Bioanalytics, a U.S.-based company specializing in blood analysis technology, to jointly develop new therapeutic solutions leveraging exosome technology.

Through this partnership, the two companies aim to combine EX Healthcare's expertise in exosome control technology with Dalton Bioanalytics' blood analysis capabilities to create innovative solutions utilizing exosomes.

A representative from EX Healthcare stated, "This MOU will lay the groundwork for conducting global clinical trials for our products. Additionally, since Dalton Bioanalytics is based at UCLA, this collaboration will help establish our credibility on an international scale."

EX Healthcare has also partnered with California University of Management and Sciences (CALUMS), a California-based institution, on a joint research project aimed at developing innovative medical solutions using exosome control technology.

Under the agreement, CALUMS will contribute expertise in data analysis and biomarker discovery, while EX Healthcare will provide its knowledge of exosome control technology.

A company representative commented, "This industry-academic collaboration marks the starting point for establishing ourselves as a company that contributes to American society. We expect this partnership to broaden our research horizons and develop new technologies to address unmet medical needs."

Meanwhile, EX Healthcare was recently recognized as an outstanding company in the Initial Startup Package Program hosted by In and Out Corporation (N15), where it successfully secured investment. The funds raised will be allocated to overseas marketing, recruitment, and research and development (R&D) initiatives.

CEO Lee Yong-hee noted, "It is exceptional for a company to be selected for the Initial Startup Package Program just three months after its establishment. Competing against other highly accomplished startups, we ultimately succeeded in securing direct investment."

Ready for a Smarter Body Care Ritual?

Discover the first exosome-powered body cream that works beneath the surface — to protect what truly matters: your strength.

Try the Ritual

Latest Stories

View all

From the Finish Line to Recovery: dermaFIT at MudoRun

From the Finish Line to Recovery: dermaFIT at MudoRun

We Ran, Recovered, and Made a Day of It at MudoRun A little sweat, lots of laughs, and a whole lot of community. MudoRun was about more than crossing the finish line. It was a day to move, connect, celebrate,...

Read more

Running Through Chinatown with NOWHERE Running

Running Through Chinatown with NOWHERE Running

On Wednesday night, dermaFIT joined the NOWHERE Running crew for an energizing community run through Chinatown. It was a great opportunity to step away from the sidelines, experience the run together, and connect with runners who share our passion for...

Read more

dermaFIT at KCON LA 2026: An Interactive Body Care Experience in Los Angeles

dermaFIT at KCON LA 2026: An Interactive Body Care Experience in Los Angeles

From August 14–16, 2026, dermaFIT joined KCON LA 2026 at the Los Angeles Convention Center for three exciting days of K-culture, community, movement, and interactive brand experiences. Throughout the weekend, visitors stopped by the dermaFIT booth at KCON Los Angeles...

Read more